                               SEQUENCE LISTING

<110> GUARDANT HEALTH, INC.
 
<120> METHODS FOR MULTI-RESOLUTION ANALYSIS OF CELL-FREE NUCLEIC ACIDS

<130> 42534-733.601

<150> 62/489,391
<151> 2017-04-24

<150> 62/4468,201
<151> 2017-03-07

<150> 62/402,940
<151> 2016-09-30

<160> 11    

<170> PatentIn version 3.5

<210> 1
<211> 36
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gctacccccc gcagcagcag cagcagcagc agcaac                                 36


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Arg Tyr Pro Pro Gln Gln Gln Gln Gln Gln Gln Gln 
1               5                   10          


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ala Thr Pro Arg Ser Ser Ser Ser Ser Ser Ser Asn 
1               5                   10          


<210> 4
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Leu Pro Pro Ala Ala Ala Ala Ala Ala Ala Ala Thr 
1               5                   10          


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Arg Tyr Pro Pro Gln Gln Gln Gln Gln Gln Gln Gln Arg 
1               5                   10              


<210> 6
<211> 12
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
gcatacgtga tg                                                           12


<210> 7
<211> 32
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
gtacccttgt ccccaggaag catacgtgat gg                                     32


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Arg Thr Leu Val Pro Arg Lys His Thr 
1               5                   


<210> 9
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Val Pro Leu Ser Pro Gly Ser Ile Arg Asp Gly 
1               5                   10      


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Tyr Pro Cys Pro Gln Glu Ala Tyr Val Met 
1               5                   10  


<210> 11
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Glu Ala Tyr Val Met 
1               5   


